HKPD Kronos AI forecast
A 30-trading-day price forecast for Cellyan Biotechnology Co. Ltd (HKPD) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Cellyan Biotechnology Co. Ltd at $5.73 on 2026-12-08, +167.8% from the last close of $2.14 on 2026-10-27. Eight out of ten sampled paths end between $5.07 and $7.04, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of HKPD
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $2.37 | $2.07 | $2.74 |
| 2026-11-10 | $2.47 | $2.31 | $3.11 |
| 2026-11-17 | $3.11 | $2.39 | $4.67 |
| 2026-11-24 | $5.27 | $3.50 | $7.33 |
| 2026-12-01 | $5.54 | $4.76 | $7.01 |
| 2026-12-08 | $5.73 | $5.07 | $7.04 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for HKPD?
- Kronos AI's median forecast for HKPD is $5.73 in 30 trading days, +167.8% from the last close, with a 10–90% range of $5.07 to $7.04.
- Is the HKPD Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- MCK — McKesson Corporation
- COR — Cencora Inc.
- CAH — Cardinal Health Inc.
- HLF — Herbalife Ltd. Common Shares
- NUS — Nu Skin Enterprises Inc.
- ZSTK — ZeroStack Corp.